Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Livzon Pharmaceutical Group ( (HK:1513) ) just unveiled an announcement.
Livzon Pharmaceutical Group Inc. announced the resignation of two independent non-executive directors, Mr. Tian Qiusheng and Mr. Wong Kam Wa, due to the expiration of their six-year term limit as per regulatory guidelines. Their departure will temporarily affect the composition of several board committees, prompting the company to expedite the election of new directors to maintain compliance with Hong Kong Listing Rules. Despite their resignations, both directors will continue their duties until successors are appointed, ensuring the board’s operations remain uninterrupted.
The most recent analyst rating on (HK:1513) stock is a Buy with a HK$48.00 price target. To see the full list of analyst forecasts on Livzon Pharmaceutical Group stock, see the HK:1513 Stock Forecast page.
More about Livzon Pharmaceutical Group
Livzon Pharmaceutical Group Inc. operates in the pharmaceutical industry, focusing on the development, production, and distribution of pharmaceutical products. The company is known for its commitment to standardized operations and has a significant presence in the market.
Average Trading Volume: 2,079,326
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$36.08B
For a thorough assessment of 1513 stock, go to TipRanks’ Stock Analysis page.